Summary by Moomoo AI
YSB Pharmaceutical Group Limited (YSB) submitted the latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on November 6, 2024, reporting the shareholding changes as of October 31, 2024. The report shows that the company's statutory/registered share capital remains unchanged at $50,000, with a par value of $0.0000025 per share, totaling 20,000,000,000 shares. As for the issued shares, the month-end balance is 644,080,446 shares, an increase of 78,351 shares from the previous month. In addition, partially exercised stock options under the share incentive plans of 2019 and 2023 have led to a decrease in the number of stock options. The total funds received from exercising options this month are $91,460.36 Hong Kong dollars. The company confirms that all issuance of securities or sales/transfers of treasury shares have been formally authorized by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.
